NCT06436066Completed
Effect of Self-Acupressure on Peripheral Neuropathic Pain and HbA1c
Effect of Self-Acupressure Application on Peripheral Neuropathic Pain and HbA1c in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 18 May 2025
Brief summary (registry, in English)
Aim: This study was conducted to examine the effect of self-applied acupressure on HbA1c and peripheral neuropathic pain in patients diagnosed with type 2 diabetes. Background: Acupressure is an effective method for relieving pain, and this effectiveness is explained by the gate control theory and endorphin theory. There is only one study in the literature showing that acupressure reduces diabetic neuropathic pain. However, in this study, acupressure was performed by a trained health professional, not by the patient himself. Measurement of glycosylated hemoglobin (HbA1c) level is one of the standard methods for long-term management of diabetes and indicates the average blood glucose concentration over a three-month period. As a result of a meta-analysis study conducted in 2023, it was reported that acupressure significantly reduced the HbA1c level. Design: This study was designed as a randomized controlled and experimental type study. Methods: The study is conducted with patients with type 2 diabetes who are followed in the diabetes outpatient clinic of a training and research hospital between May-November 2024. There are 2 arms in the study. The study is conducted with a total of 60 patients, 30 in the control group and 30 in the intervention group. Data collection tools are "Patient Information Form", "Neuropathic Pain Questionnaire - DN4", "Neuropathic Pain Questionnaire - Short Form" and "Self-Acupressure - Satisfaction Evaluation Form with Visual Analogue Scale". While patients in the control group continue to receive routine care, patients in the intervention group are given self-acupressure training. Patients who receive training perform acupressure on their own 3 days a week for 3 months and record it on the follow-up form.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 14 May 2024
- Start date
- 25 Jul 2024
- Primary completion date
- 25 Nov 2024
- Lead sponsor
- Yeditepe University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06436066
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 25 Jul 2024 to the primary completion date, 25 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Starting to use new medication to control neuropathic symptoms,
- Changing the dose of the current drug used to control neuropathic symptoms (if it is used routinely and the dose will not be changed, it can be included in the study),
- Adding a new oral antidiabetic drug to your current treatment,
Other illness
- Having a non-diabetic disease that causes neuropathy,
- Failure to comply with planned initiatives,
- Using psychiatric medication,
- Having a visual or hearing impairment,
Other
- Presence of lesion/scar/mass/open wound at the point where acupressure will be applied,
- Not using insulin normally and starting a new insulin treatment,
- The need for a new insulin dose adjustment in insulin users (individuals who currently use insulin and whose dose will not be changed can be included in the study),
- Having a mental disability or perception problem,
- Already doing self-acupressure,
- Not being willing to participate in the study is a criterion that will exclude individuals from the study.
Who the study is looking for
- 18 years and over,
- Diagnosed with type-2 diabetes,
- Diagnosed with peripheral neuropathy,
- DN4 score ≥ 4,
- Not diagnosed with a psychiatric disease,
- No hearing, visual or physical disabilities
- Knowing how to read and write,
- Able to communicate, no language problems,
- Having the equipment (smartphone, computer, tablet, etc.) to watch self-acupressure videos and receive reminder text messages,
- Patients who volunteer to participate in the study and give verbal and written consent will be included in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yeditepe University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.